Menu Back toSession 6: Driving the adoption of PROs in Clinical Practice

Advancing Patient Science Workshop


Session 6: Driving the adoption of PROs in Clinical Practice

Session Chair(s)

Tom  Willgoss, PhD, MSc

Tom Willgoss, PhD, MSc

  • Head of Late Stage Portfolio and Com., Patient Centered Outcomes Research
  • Roche Products Ltd, United Kingdom
In this session, we will take a look at what the future should and could look like for PROs: How do we ensure higher integration of PROs in routine clinical practice and that these measures become routine and part of the standard of care? How can PRO data be integrated seamlessly into the clinical workflow? How do we contextualise data collection to patients and ensure they understand the value and interact with the data (the right questions, for the right patient, at the right time)?

Speaker(s)

Christina  Akerman, DrMed, MD

The status of Health Outcomes and Transparency across Europe – why we should measure PROs and the Value this creates for all Stakeholders in the Healthcare Ecosystem

Christina Akerman, DrMed, MD

  • Affiliate Faculty at the Dell Medical School at the University of Texas at Austi
  • Affiliate Faculty At the Dell Medical School At the University of Texas At Austi, Sweden
Matthias  Rose

Levelling PROs with Clinical Outcomes – integrating patient-generated data with routine clinical data and leveraging at the point of care

Matthias Rose

  • Chair of the Department of Psychosomatic Medicine
  • Charité – Universitätsmedizin, Germany
Avril  Daly

PROs in clinical practice from the patient perspective – what drives patient adoption and what value do they provide to patients?

Avril Daly

  • CEO
  • Retina International, Ireland
Salvatore  Leone

PROs in clinical practice from the patient perspective – what drives patient adoption and what value do they provide to patients?

Salvatore Leone

  • Chairman
  • European Federation of Crohn’s and Ulcerative Colitis Federations, Belgium